We are live on
!
Find out more
RC
Renaissance Capital Portfolio holdings
AUM
$138M
1-Year Est. Return
39.59%
This Fund
S&P 500
This Quarter
Est. Return
+24.01%
1 Year Est. Return
+39.59%
3 Year Est. Return
+247.63%
5 Year Est. Return
+187.28%
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$6.88M
(+5.4%)
Cap. Flow
-$15.4M
Cap. Flow
% of AUM
-11.41%
Top 10 Holdings %
Top 10 Hldgs %
48.02%
Holding
93
New
6
Increased
6
Reduced
75
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$1.32M |
| 2 |
AZEK
The AZEK Co
AZEK
|
+$874K |
| 3 |
Sotera Health
SHC
|
+$548K |
| 4 |
MINISO
MNSO
|
+$465K |
| 5 |
Albertsons Companies
ACI
|
+$322K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Airbnb
ABNB
|
+$4.12M |
| 2 |
GFL Environmental
GFL
|
+$1.63M |
| 3 |
ONEM
1Life Healthcare
ONEM
|
+$1.11M |
| 4 |
Beam Therapeutics
BEAM
|
+$908K |
| 5 |
SGFY
Signify Health, Inc.
SGFY
|
+$852K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.05% |
| 2 | Consumer Discretionary | 29.45% |
| 3 | Healthcare | 10.93% |
| 4 | Financials | 9.86% |
| 5 | Communication Services | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Procore
PCOR
$8.26B
| $1.48M | 1.1% |
23,657
-2,526
| -10% | -$148K |
|
27
Shift4
FOUR
$4.2B
| $1.27M | 0.94% |
16,782
-1,775
| -10% | -$114K |
|
|
RXDX
28
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $1.23M | 0.91% |
+11,503
| New | +$1.32M |
|
29
Shoals Technologies Group
SHLS
$1.47B
| $1.23M | 0.91% |
53,787
+3,265
| +6% | +$80.6K |
|
30
Doximity
DOCS
$3.76B
| $1.2M | 0.89% |
37,169
-4,011
| -10% | -$133K |
|
31
Applovin
APP
$133B
| $1.15M | 0.85% |
72,744
-7,601
| -9% | -$99.6K |
|
32
Duolingo
DUOL
$6.28B
| $1.13M | 0.84% |
7,949
-626
| -7% | -$64.3K |
|
33
Ryan Specialty Holdings
RYAN
$5.72B
| $1.11M | 0.83% |
27,699
-2,974
| -10% | -$122K |
|
34
Allegro MicroSystems
ALGM
$7.73B
| $1.06M | 0.78% |
22,031
-2,287
| -9% | -$93.1K |
|
35
SentinelOne
S
$6.53B
| $1.04M | 0.77% |
63,469
-6,728
| -10% | -$102K |
|
|
EDR
36
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $1.03M | 0.77% |
43,204
-3,986
| -8% | -$88.8K |
|
|
CFLT
37
DELISTED
Confluent
CFLT
| $993K | 0.74% |
41,274
-4,406
| -10% | -$102K |
|
|
NARI
38
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $984K | 0.73% |
15,943
-1,710
| -10% | -$103K |
|
|
DNB
39
DELISTED
Dun & Bradstreet
DNB
| $981K | 0.73% |
83,544
-8,979
| -10% | -$114K |
|
40
DigitalOcean
DOCN
$13.7B
| $902K | 0.67% |
23,030
-2,392
| -9% | -$75.3K |
|
41
Vaxcyte
PCVX
$7.81B
| $888K | 0.66% |
23,688
-2,548
| -10% | -$108K |
|
42
Legend Biotech
LEGN
$3.59B
| $882K | 0.65% |
18,300
-1,958
| -10% | -$95.8K |
|
43
Global E Online
GLBE
$6.6B
| $875K | 0.65% |
27,134
-2,788
| -9% | -$76.4K |
|
|
AZEK
44
DELISTED
The AZEK Co
AZEK
| $870K | 0.64% |
+36,949
| New | +$874K |
|
45
DoubleVerify
DV
$1.73B
| $859K | 0.64% |
28,506
+1,647
| +6% | +$43.1K |
|
46
Kanzhun
BZ
$7.27B
| $853K | 0.63% |
44,798
-4,779
| -10% | -$104K |
|
47
Affirm
AFRM
$23.9B
| $828K | 0.61% |
73,439
-6,400
| -8% | -$80.6K |
|
|
XM
48
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $755K | 0.56% |
42,325
-3,367
| -7% | -$51.5K |
|
49
Mobileye
MBLY
$2B
| $679K | 0.5% |
15,687
-1,618
| -9% | -$63.4K |
|
50
Marqeta
MQ
$1.83B
| $654K | 0.48% |
35,790
-3,875
| -10% | -$86.5K |
|
Similar funds
LDNAM
PF
DW
FP
SIP
TC
PBRA
LPAM
Renaissance Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Capital held 93 positions worth $135M, up 5.4% from $128M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Renaissance Capital withdrew a net $15.4M in Q1 2023, closing 5 positions and reducing 75 holdings. Its most notable exit was GFL Environmental, an estimated $1.63M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Renaissance Capital opened a new position in Prometheus Biosciences, Inc. Common Stock worth $1.23M.
- Renaissance Capital's largest Q1 2023 buy was Prometheus Biosciences, Inc. Common Stock: 11,503 shares worth $1.23M.
- Renaissance Capital added most to Albertsons Companies in Q1 2023, an estimated $322K increase.
- Renaissance Capital's biggest Q1 2023 reduction was Airbnb, cutting an estimated $4.12M.
- Renaissance Capital fully exited GFL Environmental in Q1 2023, selling an estimated $1.63M.
- Renaissance Capital's ten largest holdings make up 48% of its $135M portfolio in Q1 2023.
- Renaissance Capital opened 6 new positions and closed 5 in Q1 2023.
- Renaissance Capital's portfolio value rose 5.4% quarter-over-quarter to $135M.
Based on Renaissance Capital's 13F filing for Q1 2023, filed 11 Apr 2023.